Key Financial Data Of Group

Carna Biosciences, Inc. - Filing #7712030

Concept 2019-01-01 to
2019-03-31
As at
2019-03-31
As at
2018-12-31
2018-01-01 to
2018-12-31
As at
2018-03-31
2018-01-01 to
2018-03-31
Key financial data of group
Business results of group
Net sales
169,964,000 JPY
754,691,000 JPY
211,132,000 JPY
Ordinary profit (loss)
-235,883,000 JPY
-1,159,223,000 JPY
-191,334,000 JPY
Profit (loss) attributable to owners of parent
-236,814,000 JPY
-1,210,573,000 JPY
-194,481,000 JPY
Comprehensive income
-236,252,000 JPY
-1,212,712,000 JPY
-198,024,000 JPY
Net assets
847,333,000 JPY
887,453,000 JPY
1,179,883,000 JPY
Total assets
1,600,967,000 JPY
1,770,090,000 JPY
2,226,643,000 JPY
Basic earnings (loss) per share
-23.16
-125.02
-20.36
Diluted earnings per share
Equity-to-asset ratio
0.527 xbrli:pure
0.497 xbrli:pure
0.523 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.